Background illustration for clinical trials search

Paid Clinical Trials Reno

Discover 149 paid clinical trials in Reno, Nevada. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
FeaturedActive & Responsive

A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251

for
Geographic Atrophy
Location: Reno NV, Sacramento CA, San Francisco CA,
Sponsor: Genentech, Inc.

Sex: All

Age: 50+

Code: NCT05626114

Phase 2, Recruiting
FeaturedActive & Responsive

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

for
Metastatic Breast Cancer
Location: Reno NV, Los Angeles CA, Duarte CA, Irvine CA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT03424005

Phase 1, Phase 2, Recruiting
Featured

Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema

for
Diabetic Retinopathy
Location: Reno NV, Walnut Creek CA, San Francisco CA,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07592273

Phase 2, Phase 3, Recruiting
Featured

Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

for
Neovascular Age-related Macular Degeneration
Location: Reno NV, Sacramento CA, San Francisco CA,
Sponsor: AbbVie

Sex: All

Age: 50+

Code: NCT07007065

Phase 3, Recruiting
Featured

A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

for
Lymphoma
Location: Reno NV, Los Angeles CA, Duarte CA, Santa Monica CA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06084936

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Featured

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

for
Non-Small Cell Lung Cancer, c-MET
Location: Reno NV, Oxnard CA, Los Angeles CA, Ogden UT, Tacoma WA,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06568939

Phase 2, Recruiting
Featured

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

for
Parkinson's Disease
Location: Reno NV, San Francisco CA, Palo Alto CA, Stanford CA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 50 - 70+

Code: NCT07174310

Phase 3, Recruiting
Featured

A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

for
Non-Squamous Non-Small Cell Lung Cancer, c-MET
Location: Reno NV, Duarte CA, Santa Monica CA, Los Angeles CA,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07005102

Phase 2, Phase 3, Recruiting
Featured

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata

for
Alopecia Areata
Location: Reno NV, Sacramento CA, Las Vegas NV, Thousand Oaks CA,
Sponsor: AbbVie

Sex: All

Age: 12 - 63

Code: NCT06012240

Phase 3, Recruiting
Featured

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Location: Reno NV, Roseville CA, Greenbrae CA, Clovis CA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06793215

Phase 3, Recruiting
Featured

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

for
Epithelial Ovarian Cancer, Fallopian Tube Cancer,
Location: Reno NV, San Francisco CA, Eugene OR, Los Angeles CA,
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT06890338

Phase 2, Recruiting
Active & Responsive

Helix Research Network

for
Genetic Predisposition to Disease, Genetics Disease
Location: Reno NV, Sioux Falls SD, Omaha NE, Bloomington MN,
Sponsor: Helix, Inc

Sex: All

Age: 18+

Code: NCT06057181

Recruiting
Active & Responsive

An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)

for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Reno NV, Dallas TX, La Crosse WI, Carmel IN
Sponsor: Complement Therapeutics

Sex: All

Age: 55+

Code: NCT07392255

Phase 1, Phase 2, Recruiting
Active & Responsive

A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)

for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Reno NV, Dallas TX, La Crosse WI, Springfield IL,
Sponsor: Complement Therapeutics

Sex: All

Age: 55+

Code: NCT07144137

Recruiting
Active & Responsive

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

for
Intestinal Neoplasms, Gastrointestinal Neoplasms,
Location: Reno NV, Roseville CA, Sacramento CA, Santa Rosa CA,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07222800

Phase 3, Recruiting
Active & Responsive

Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System in Nevada and Mississippi: State-Based Initiative Component

for
Lung Cancer Screening
Location: Reno NV, Hawthorne NV, Winnemucca NV, Pahrump NV,
Sponsor: Timothy Mullett

Sex: All

Age: 18 - 70+

Code: NCT07682597

Recruiting
Active & Responsive

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

for
Triple Negative Breast Neoplasms
Location: Reno NV, San Francisco CA, Boise ID, Las Vegas NV,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06841354

Phase 3, Recruiting
Active & Responsive

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

for
PIK3CA Mutation, Solid Tumor, Adult,
Location: Reno NV, Salt Lake City UT, San Diego CA, Tucson AZ,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05216432

Phase 1, Recruiting
Active & Responsive

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

for
Pulmonary Hypertension, Interstitial Lung Disease (ILD)
Location: Reno NV, Riverside CA, Salt Lake City UT, Phoenix AZ,
Sponsor: Tempus AI

Sex: All

Age: 18+

Code: NCT06911632

Recruiting
Active & Responsive

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

for
Cardiovascular Disease
Location: Reno NV, Roseville CA, Stockton CA, Walnut Creek CA,
Sponsor: Amgen

Sex: All

Age: 50 - 70+

Code: NCT07136012

Phase 3, Recruiting